Skip to content

Castror Oil for Labor Induction in Women With Previous Cesarean Section

The Use of Castor Oil for Induction of Labour in Women With Previous Caesarean Delivery: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03958981
Enrollment
70
Registered
2019-05-22
Start date
2019-07-15
Completion date
2020-07-15
Last updated
2021-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of Labor

Brief summary

Nowadays, more and more women embark on pregnancy with previous Caesarean scar. One in five pregnancies requires induction of labour. The use of non-pharmacological methods (methods without using medication) has been gaining popularity for women who are not good candidates, such as women with previous Caesarean scar, for induction with medications such as prostaglandin. Labour induction with prostaglandin carries a higher risk of uterine rupture and thus it is not routinely offered to women with previous Caesarean delivery in Cairo University Hospital. Non-pharmacological methods of induction of labour appear to be safe in women with previous Caesarean delivery. However, various methods are available and the efficacy among them remain in doubt.

Detailed description

In Cairo University Hospital, castor oil, which is a type of induction methods, is routinely offered to women with previous Caesarean delivery who require induction of labor. However, castor oil may not exert its labor induction effect immediately and the delivery may be delayed by up to 8 days. This may render a proportion of women resort to repeated Caesarean section for failed induction. Castor oil is traditionally given by midwives in order to induce labor. The investigators are intent to recruit 70 healthy pregnant women with a history of previous one cesarean section and with no contraindication to trial of labor after cesarean . Women will be randomly and blindly divided into equal-sized intervention group and control group. Intervention group will be given a single dose 60 mL of castor oil in 140 mL of orange juice, while control group will be given a placebo with similar texture. Primary outcomes to be tested are the percentage of women entering active labor within 24 hours of castor oil or placebo administration and the number of successful vaginal deliveries after cesarean.

Interventions

The intervention group will be given 60 mL of castor oil in 140 mL of orange juice

DRUGplacebo

the control group will be given a sunflower oil as a placebo with a similar texture to castor oil

Sponsors

Mohamed El Sharkawy
CollaboratorUNKNOWN
Yomna Bayoumi
CollaboratorUNKNOWN
mohamed hisham gouda
CollaboratorUNKNOWN
Dina latif
CollaboratorUNKNOWN
Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women with one previous lower segment Caesarean section who are admitted to Cairo University Hospital for induction of labor (IOL) will be recruited. The inclusion criteria are age at least 20 years old, gestational age at recruitment from 36 weeks to 38 weeks ±6 days, gestational age at induction= 39 weeks, singleton pregnancy, reassuring fetal status, and Bishop score ≤ 6.

Exclusion criteria

* Prior high-risk uterine scar; uterine rupture, classical CS, hysterotomy, or myomectomy * Short inter-delivery interval (\<12 months) * Complications in the previous CS (e.g. puerperal sepsis) Obstetric indication for CS (either elective or emergency): * Placenta praevia * Placental abruption * Documented evidence of cephalopelvic disproportion * Fetal macrosomia (estimated fetal weight \>4 kg) * Fetal anomalies interfering with vaginal delivery e.g. hydrocephalus * Fetal distress or non-reassuring Cardiotocography pattern

Design outcomes

Primary

MeasureTime frameDescription
Percentage of women entering active phase within 24 hours of administering castor oil/placebotwo weeksActual time of delivery
number of successful VBAC cases24 hoursnumber of successful cases who delivered vaginally

Secondary

MeasureTime frameDescription
Neonatal apgar scores1 minute and 5 minute after deliveryNeonatal APGAR scores
Neonatal complications including hospitalization in NICUimmediately after birthWere there any admissions to NICU, what was the reason ?
Mode of delivery (ie. Normal delivery Vs. Cesarean delivery)Within two weeks of enrollmentMode of delivery
duration of labor24 hoursduration of labor in hours
number of cases needing oxytocin augmentation24 hoursnumber of cases needing oxytocin augmentation

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026